AVADEL PHARMACEUTICALS PLC — Director's Dealing 2017

Jun 30, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2017-06-28

Reporting Person: Thornton Peter J. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-28	Stock Option (right to buy)	$10.51	A	30000	Acquired	2022-06-28	ADSs (30000)	Direct

Footnotes

F1: Options become exercisable as to all 30,000 ADSs on the first anniversary of the 06/28/2017 grant date.

F2: The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.